|
US5643578A
(en)
|
1992-03-23 |
1997-07-01 |
University Of Massachusetts Medical Center |
Immunization by inoculation of DNA transcription unit
|
|
US6165993A
(en)
*
|
1992-03-23 |
2000-12-26 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
|
US5620896A
(en)
*
|
1992-03-23 |
1997-04-15 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
|
US6127116A
(en)
*
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
|
GB9709900D0
(en)
*
|
1997-05-15 |
1997-07-09 |
Microbiological Res Authority |
Microencapsulated DNA for vaccination and gene therapy
|
|
EP0965336A1
(en)
*
|
1995-11-09 |
1999-12-22 |
Microbiological Research Authority |
Microencapsulated DNA for gene therapy
|
|
US5741492A
(en)
*
|
1996-01-23 |
1998-04-21 |
St. Jude Children's Research Hospital |
Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
|
|
US6723558B1
(en)
|
1996-01-23 |
2004-04-20 |
St. Jude Children's Research Hospital |
Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
|
|
AU2118997A
(en)
*
|
1996-02-05 |
1997-08-22 |
Johns Hopkins University, The |
Measles immunization by dna transcription unit inoculation
|
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
ATE309366T1
(de)
*
|
1996-02-22 |
2005-11-15 |
Merck & Co Inc |
Synthetische hiv-gene
|
|
AU728422B2
(en)
*
|
1996-06-21 |
2001-01-11 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
AU3514197A
(en)
|
1996-07-03 |
1998-01-21 |
Genetics Institute Inc. |
Protease fmh-1, an ice/ced-like protease
|
|
FR2751225B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique aviaire
|
|
FR2751223B1
(fr)
|
1996-07-19 |
1998-12-04 |
Rhone Merieux |
Formule de vaccin polynucleotidique felin
|
|
FR2751228B1
(fr)
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Vaccin polynucleotidique bovin pour voie intradermique
|
|
FR2751227B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
|
US7294338B2
(en)
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
FR2751229B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
|
|
FR2751224B1
(fr)
*
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
|
|
FR2751226B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies du cheval
|
|
US5783567A
(en)
*
|
1997-01-22 |
1998-07-21 |
Pangaea Pharmaceuticals, Inc. |
Microparticles for delivery of nucleic acid
|
|
US6696291B2
(en)
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
|
CN1044092C
(zh)
|
1997-02-26 |
1999-07-14 |
上海医科大学 |
抗原-抗体-重组dna复合型疫苗
|
|
US7049428B1
(en)
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
|
UA78180C2
(uk)
|
1997-10-03 |
2007-03-15 |
Меріаль |
Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
|
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
|
WO1999065531A1
(en)
|
1998-06-18 |
1999-12-23 |
Johns Hopkins University School Of Medicine |
Polymers for delivery of nucleic acids
|
|
US6916490B1
(en)
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
|
GB9818627D0
(en)
|
1998-08-26 |
1998-10-21 |
Glaxo Group Ltd |
Improvements in dva vaccination
|
|
US6881723B1
(en)
|
1998-11-05 |
2005-04-19 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
US7022320B1
(en)
|
1999-02-09 |
2006-04-04 |
Powderject Vaccines, Inc. |
Mycobacterium tuberculosis immunization
|
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
|
US6852705B2
(en)
|
2000-01-21 |
2005-02-08 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
US7078388B2
(en)
|
2000-01-21 |
2006-07-18 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
AUPS054702A0
(en)
|
2002-02-14 |
2002-03-07 |
Immunaid Pty Ltd |
Cancer therapy
|
|
US6982156B2
(en)
|
2002-03-27 |
2006-01-03 |
Trustees Of The University Of Pennsylvania |
Compositions and methods modulating variola and vaccinia virus
|
|
US6783759B2
(en)
|
2002-03-27 |
2004-08-31 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for modulating variola virus
|
|
WO2005035771A2
(en)
|
2003-10-10 |
2005-04-21 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
BRPI0415533A
(pt)
|
2003-10-24 |
2006-12-26 |
Immunaid Pty Ltd |
método de terapia
|
|
CN100549021C
(zh)
|
2004-05-27 |
2009-10-14 |
森托科尔公司 |
猕猴前列腺特异性抗原
|
|
US20060121031A1
(en)
|
2004-12-07 |
2006-06-08 |
Mckenzie Brent S |
Relay vaccine
|
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
|
MX2009012924A
(es)
|
2007-06-08 |
2010-03-25 |
Australian Poultry Crc Pty Ltd |
Toxina clostridial netb.
|
|
WO2009026660A1
(en)
|
2007-08-30 |
2009-03-05 |
Walter And Eliza Hall Institute Of Medical Research |
Dendritic cell marker and uses thereof
|
|
DK2435825T3
(en)
|
2009-05-27 |
2015-10-19 |
Biotempus Ltd |
Modes for medical care
|
|
TWI627281B
(zh)
|
2009-09-02 |
2018-06-21 |
百靈佳殷格翰家畜藥品公司 |
降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
|
|
RU2578420C2
(ru)
|
2010-05-10 |
2016-03-27 |
Эсенд Байофармасьютикалз Пти Лтд |
Иммуностимулирующие и вакцинные композиции
|
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
|
WO2013033092A2
(en)
|
2011-09-03 |
2013-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Streptococcus suis pilus antigens
|
|
JP2015504413A
(ja)
|
2011-10-28 |
2015-02-12 |
パトリス リミテッド |
Pat−lm1エピトープおよびそれを使用するための方法
|
|
EP2958586B1
(en)
|
2013-02-21 |
2018-09-05 |
Boehringer Ingelheim Vetmedica GmbH |
H5 proteins of h5n1 influenza virus for use as a medicament
|
|
CA2943816A1
(en)
|
2014-04-03 |
2015-10-08 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine epidemic diarrhea virus vaccine
|
|
WO2016000022A1
(en)
|
2014-06-30 |
2016-01-07 |
Murdoch Childrens Research Institute |
Helicobacter therapeutic
|
|
EP3344289B1
(en)
|
2015-08-31 |
2020-01-29 |
Boehringer Ingelheim Vetmedica GmbH |
Pestivirus vaccines for congenital tremors
|
|
US20170072042A1
(en)
|
2015-09-16 |
2017-03-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Salmonella choleraesuis-salmonella typhimurium vaccines
|
|
MX391049B
(es)
|
2016-09-20 |
2025-03-21 |
Boehringer Ingelheim Vetmedica Gmbh |
Nuevos promotores
|
|
MX2019003161A
(es)
|
2016-09-20 |
2019-05-27 |
Boehringer Ingelheim Vetmedica Gmbh |
Nuevo sitio de insercion orf70 de ehv.
|
|
ES2956050T3
(es)
|
2016-09-20 |
2023-12-12 |
Boehringer Ingelheim Vetmedica Gmbh |
Vectores de adenovirus caninos
|
|
UY37408A
(es)
|
2016-09-20 |
2018-03-23 |
Boehringer Ingelheim Vetmedica Gmbh |
Vacuna de vectores contra el virus de la gripe “a” porcina
|
|
EP4570264A3
(en)
|
2016-11-03 |
2026-01-21 |
Boehringer Ingelheim Vetmedica GmbH |
Vaccine against porcine parvovirus
|
|
UA130511C2
(uk)
|
2016-11-03 |
2026-03-11 |
Бьорінгер Інгельхайм Ветмедіка Гмбх |
Вакцина проти свинячого парвовірусу й вірусу свинячого репродуктивного й респіраторного синдрому та спосіб її одержання
|
|
WO2018140766A2
(en)
|
2017-01-30 |
2018-08-02 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine coronavirus vaccines
|
|
JP7083362B2
(ja)
|
2017-07-12 |
2022-06-10 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
セネカウイルスa免疫原性組成物およびその方法
|
|
MX2020003071A
(es)
|
2017-09-23 |
2020-07-28 |
Boehringer Ingelheim Vetmedica Gmbh |
Sistema de expresion de paramyxoviridae.
|
|
WO2019092027A1
(en)
|
2017-11-09 |
2019-05-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Sapelovirus immunogenic compositions and uses thereof
|
|
US11033616B2
(en)
|
2018-02-23 |
2021-06-15 |
Boehringer Ingelheim Vetmedica Gmbh |
Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
|
|
JP7245260B2
(ja)
|
2018-03-19 |
2023-03-23 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー |
Ehv挿入部位ul43
|
|
CA3091954A1
(en)
|
2018-03-19 |
2019-09-26 |
Boehringer Ingelheim Vetmedica Gmbh |
New ehv with inactivated ul18 and/or ul8
|
|
CN119488586A
(zh)
|
2018-03-26 |
2025-02-21 |
勃林格殷格翰动物保健美国有限公司 |
制备免疫原性组合物的方法
|
|
US11464852B2
(en)
|
2018-09-20 |
2022-10-11 |
Boehringer Ingelheim Vetmedica Gmbh |
Modified PEDV spike protein
|
|
EP3852800A1
(en)
|
2018-09-20 |
2021-07-28 |
Boehringer Ingelheim Vetmedica GmbH |
Intranasal vector vaccine against porcine epidemic diarrhea
|
|
WO2021158878A1
(en)
|
2020-02-06 |
2021-08-12 |
Boehringer Ingelheim Animal Health USA Inc. |
Polypeptides useful for detecting anti-rhabdovirus antibodies
|
|
CN116438202A
(zh)
|
2020-10-05 |
2023-07-14 |
勃林格殷格翰动物保健美国有限公司 |
包含圆环病毒科衣壳蛋白的融合蛋白及其构成的嵌合病毒样颗粒
|
|
WO2022076979A1
(en)
|
2020-10-05 |
2022-04-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Fusion protein useful for vaccination against rotavirus
|
|
JP2025511739A
(ja)
|
2022-04-05 |
2025-04-16 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー |
ロタウイルスに対するワクチン接種のために有用な免疫原性組成物
|